The European Medicines Agency (EMA) alerted Infarmed about the circulation of counterfeit Ozempic containers, injectable diabetes medication, but In Portugal, no counterfeit units have yet been detectedas reported by the national authority this Thursday.
“Infarmed was informed by the EMA, as well as by some similar authorities, of the detection and suspicion of counterfeit units of the medicine Ozempic, semaglutide, solution for injection in pre-filled pen (various doses) in some countries on the European market. However, until the To date, no counterfeit units of the aforementioned medication have been detected in the national distribution chain,” reads a note published on the official website of Infarmed – National Medicines Authority.
According to the note, Infarmed “is in contact with the different participants in the medication circuit, so that they can be even more alert in this specific situation,” and remembers that The purchase of medicines should only be made in pharmacies.or in the case of medicines not subject to a medical prescription, in authorized establishments, highlighting that they cannot be sold online.
“The EMA, at the European level, is also investigating this situation, together with the drug regulatory authorities of the European Union (EU) and with the help of law enforcement entities. The objective is to alert all those involved in the drug circuit of the EU, due to the possibility of marketing counterfeit presentations of the aforementioned medicine,” the note reads.
Official information reminds that Counterfeit medicines “present a risk to public health.”
Source: TSF
